日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

CHD1 缺失会重编程 SREBP2 驱动的胆固醇合成,从而促进 SPOP 突变前列腺肿瘤的雄激素反应性生长和去势抵抗

Chen Feiyu, Li Haoyan, Wang Yin, Tang Ximing, Lin Kevin, Li Qidong, Meng Chenling, Shi Wei, Leo Javier, Liang Xin, Zhang Jie, Van Vivien, Mahmud Iqbal, Wei Bo, Lorenzi Philip L, Raso Maria G, Aparicio Ana, Lu Yue, Frigo Daniel E, Gan Boyi, Zhao Di

Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer

瘦素水平与晚期前列腺癌患者的冠状动脉钙化有关

Koutroumpakis, Efstratios; Venkatesh, Neha; Aparicio, Ana; Song, Juhee; Panaretakis, Theocharis; Deswal, Anita; Logothetis, Christopher J; Frigo, Daniel E; Hahn, Andrew W

GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials

GLP-1受体激动剂在局限性前列腺癌男性患者中的应用:叙述性综述及前瞻性临床试验的理论依据

Fang, Andrew; Frigo, Daniel E; Hahn, Andrew; Razouki, Zayd; Hwang, Jessica; Koutroumpakis, Efstratios; Lawen, Tarek; Smith, Matthew; Hamilton-Reeves, Jill; DiGiovanni, John; Higgason, Noel; Garcia, Rebekka S; Chapin, Brian F; Pettaway, Curtis; Chery, Lisly; Troncoso, Patricia; Logothetis, Christopher; Daniel, Carrie R; Wei, Peng; Gregg, Justin R

Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers

揭示前列腺癌中铁死亡的奥秘——通往新型疗法和影像学标志物的道路

Cao, Pham Hong Anh; Dominic, Abishai; Lujan, Fabiola Ester; Senthilkumar, Sanjanaa; Bhattacharya, Pratip K; Frigo, Daniel E; Subramani, Elavarasan

Body composition in recurrent prostate cancer and the role of steroidogenic genotype

复发性前列腺癌患者的身体成分及类固醇生成基因型的作用

Venkatesh, Neha; Tidwell, Rebecca S; Yu, Yao; Aparicio, Ana; Zurita, Amado J; Subudhi, Sumit K; Siddiqui, Bilal A; Mukhida, Sagar S; Gregg, Justin R; Corn, Paul G; Koutroumpakis, Efstratios; McQuade, Jennifer L; Frigo, Daniel E; Pilie, Patrick G; Huff, Chad; Logothetis, Christopher J; Hahn, Andrew W

Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer

前列腺癌亚型和部位特异性诱导的代谢脆弱性

Mossa, Federica; Robesti, Daniele; Sumankalai, Ramachandran; Corey, Eva; Titus, Mark; Kang, Yuqi; Zhang, Jianhua; Briganti, Alberto; Montorsi, Francesco; Vellano, Christopher P; Marszalek, Joseph R; Frigo, Daniel E; Logothetis, Christopher J; Gujral, Taranjit S; Dondossola, Eleonora

Editorial: Metabolic regulation under oxidative stress in cancer

社论:癌症氧化应激下的代谢调控

Subramani, Elavarasan; Dominic, Abishai; Bhattacharya, Pratip K; Frigo, Daniel E; Bederman, Ilya; Vaziri-Gohar, Ali

Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer

雄激素受体在前列腺癌中的癌细胞外在作用

Hahn, Andrew W; Siddiqui, Bilal A; Leo, Javier; Dondossola, Eleonora; Basham, Kaitlin J; Miranti, Cindy K; Frigo, Daniel E

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

怪事:雄激素受体在前列腺癌以外的肿瘤学领域的新角色和机遇

Leo, Javier; Dondossola, Eleonora; Basham, Kaitlin J; Wilson, Nathaniel R; Alhalabi, Omar; Gao, Jianjun; Kurnit, Katherine C; White, Michael G; McQuade, Jennifer L; Westin, Shannon N; Wellberg, Elizabeth A; Frigo, Daniel E

Systemic Ablation of Camkk2 Impairs Metastatic Colonization and Improves Insulin Sensitivity in TRAMP Mice: Evidence for Cancer Cell-Extrinsic CAMKK2 Functions in Prostate Cancer.

系统性消除 Camkk2 可损害 TRAMP 小鼠的转移性定植并改善其胰岛素敏感性:前列腺癌中癌细胞外源性 CAMKK2 功能的证据

Pulliam Thomas L, Awad Dominik, Han Jenny J, Murray Mollianne M, Ackroyd Jeffrey J, Goli Pavithr, Oakhill Jonathan S, Scott John W, Ittmann Michael M, Frigo Daniel E